ILIS'U -3 ‘
CWMP thALI-mj M Nos 3’500/3

 

PATIENT HISTORY: - db ML _. W was 6 50 , 9
The patient is a year-oId female with no clinical history given. Date of ast menstrual period: Not given. A 9/97“
PRE OP DIAGNOSIS: Breast cancer. )0,
POST 0P DIAGNOSIS: Same. ,
PROCEDURE: Left total mastectomy and seminal node biopsy, Hepatitis C. "Um-$2%F:3;::°;;3;18g:;5?;-Armmsgagda cte d
Ilia. I IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII

III IIII'IIIIIIIIIIIIII IIII'IIIIIIIIIII . "
FINAL DIAGNOSIS: ll||IIIIIII|I|||I|||IIII

PART 1: SENTINEL LYMPH NODE, LEFT. #1 —
LYMPH NODE POSITIVE FOR SEVERAL MICROMETASTASES. APPROXIMATELY 0.1 CM EACH. VISIBLE ON
IMMUNOSTAIN SLIDES AND TWO LEVELS OF THE H&E STAIN SECTIONS.

PART 2: SENTINEL LYMPH NODE, LEFT , #2 -
NEGATIVE FOR METASTATIC TUMOR (see comment).

PART 3: NON-SENTINEL LYMPH NODE, LEFT -
NEGATIVE FOR METASTATIC TUMOR.

PART 4: BREASTﬂFT TOTAL MASTECTOMY -

A. INFILTRATING‘ CTAL CARCINOMA, NOTTINGHAM SCORE 719 (TUBULES 3. NUCLEAR PLEOMORPHISM 2,
MITOSIS 1) 5.0 x 5.0 x 0.0 CM.

8. OUCTAL CARCINOMA IN SITU, SOLID AND CRIBRIFORM TYPES REPRESENTING, APPROXIMATELY 5% OF TOTAL
TUMOR VOLUME.

c. SKIN WITH TUMOR IN THE LOWER OERMIs.

D. LINES OF RESECTION ARE FREE OF TUMOR. (See comment)

4

I
1

COMMENT: '
The tumor is approximately 0.1 cm from the inferior surgicaI resection margin. The ductal nature of me tumor Is
confirmed by a strongly positive E-cadherin Immunostain.

inter]:
giganosiz DIscrEpancy
Prim ary In In -
. a '
r Site Ducrepam y
\\ x \
\

 
 
   

HII' Discrnpancy
\
Prior Malignancy H s: r

   
 

MICROSCOPIC:
SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST

A. Lateraiity: g
1. Right 2. Left
B. Procedure: 1
1. Segmentectomy 3. Modiﬁed radical mastectomy
2. Simple mastectomy 4. Re-excision
C. Location: 2
1. Central subareolar 4. L00
2. U00 5. HQ
3. UIQ 6. Not speciﬁed

D. Size of tumor (maximum dimension invasive component by gross or microscopic exam): §._0 cm
E. Type (Invaswe componer It]. 1

1. Ductal. NOS 5. Cribriform 9. Metaplastic
2. Tubular 6. Papillary 10. Other
3. Mucinous ' 7. Lobular
4. Medullary 8. Carcinoid like
F. If lobular carcinoma, specify type: M ,
1. Classical 4. Signet ring 7. Pleomorphic
2. Solid 5. Trabecular
3. Alveolar ‘ 6. Tubulobular

G. Nottingham Score:
G1. Nuclear grade: Q
62. Tubule formation: a
Ga. Mitotic activity score: _1_
G4. Total Nottingham score: 2
G5. Nottingham grade (1, 2, 3): g
H. Angiolymphatic invasion: 1

1. No 2. Yes
I. Dermal lymphatic invasion: g
1. Yes 2. No 3. Not applicable
J. Calciﬁcation: 1
1. No 2. Yes — benign zones 3. Yes — malignant zones
K. Type of in situ component: 11;
1. Cribn‘form 4. Micropapillary 7. Lobular
2. Solid 5. Apocrine
3. Papillary 6. Comedo

L. Percentage of tumor occupied by in situ component: §%
M. Surgical margins involved by invasive component: 1

1. No 2. Yes — focal 3. Yes — diffuse
N. Surgical margins involved by in situ component: 1

1. No 2. Yes - focal 3. Yes - diffuse
O. Paget’s disease of nipple: 2

1. Yes 2. No

P. Number of positive lymph nodes: 1
Q. Total number of lymph nodes examined: 3
R. Sentinel node metastasis: 1

1. Yes 2. No
8. Only micrometastases to lymph nodes (none larger than 0.2 cm): 1
1. Yes 2. No
T. Metastasis/es to a lymph node 2 cm. or more in greatest dimension: 2
1. Yes 2. No
U. Lymph node metastasis/es with extracapsular extension: 2
1. Yes 2. No
V. Metastases to ipsilateral internal mammary lymph node (if applicable): MA
1. Yes 2. No
W. Skin involved (ulceration): M
1. Yes 2. NO
X. Non-neoplastic breast tissue: § .
1. ADH 4. Fibroadenoma 7. LCIS
2. ALH 5. Papilloma 8. Other
3. Radical scar 6. FCD
Y. Multicentricitylmultifocality of invasive loci: 2
1. Yes 2. No

Y1: Sizes of invaxive foci: # cm I # cm / # cm
Y2: Aggregate diameter of Y1 tumors: # cm
Z. TNM stage: T ,3 N _1_M 5 __-.

 

 

 

Primary TlmoMcreoancy /‘

HIi‘AA Dlsm pansy “N

_—K.

Prior Malignancy History _— ~
‘.

Dual/Synchdaﬂ.
_‘ ___ _ _ __.
EiﬂL- . QUALIFIED / _Tlscununan —
Rcvxewer Initial, __ ’_ "‘ ————_ ._..

1_ _1 Date Revisited. ___/_/_ —

 

CrlterB y“ 4‘
DiaznosisMrepancy ..

 

 

 

 

 
  

 

 

 

I l "i

